Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Organic program comment period extended

This article was originally published in The Tan Sheet

Executive Summary

The Department of Agriculture adds 60 days for public comment on its recent release of an interim final rule expanding the number of synthetic substances approved under the National Organic program, according to a June 27 Federal Register notice. The rule, proposed May 15, calls for amending the agency's National List of Allowed and Prohibited Substances to add 38 non-organic ingredients recommended by the National Organic Standards Board to the national list. The Natural Products Association supports making more ingredients available for organic use, but is concerned the rule has no explicit provision calling for the removal of these synthetics ingredients from the list once they are deemed no longer necessary (1"The Tan Sheet" May 28, 2007, p. 13)...

You may also be interested in...

NPA Concerned By USDA Proposal To Expand National Organic Program List

An Agriculture Department proposal to expand the number of synthetic substances approved for the National Organic Program may not adequately address procedures for removing items in the event of contamination or other problems, according to the National Products Association

Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty

The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts